目的: 研制首批N, S-二乙酰半胱氨酸国家药品对照品,用于氨基酸类药品有关物质的检查,控制相关药品质量,保证患者用药安全。方法: 采用高效液相色谱、红外吸收光谱、高分辨质谱及核磁共振谱对N, S-二乙酰半胱氨酸化学结构进行确证,检查其水分、炽灼残渣、无机离子、残留溶剂、有关物质等杂质的含量,采用液相色谱法、核磁共振谱定量法及质量平衡法对其含量进行测定和计算,并采用质量平衡法对其含量进行赋值,考察了其引湿性、均匀性和短期稳定性。 结果与结论: 试验确证了N, S-二乙酰半胱氨酸的分子结构,测得水分为0.05%,无机离子为0.21%,有关物质为0.90%,未检出残留溶剂。以质量平衡法赋值首批N, S-二乙酰半胱氨酸对照品,含量为98.8%。本批次对照品含量分布均匀,试验结果证明N, S-二乙酰半胱氨酸短期内稳定。
Objective: To establish the first batch of national drug reference standard of N, S-diacetylcysteine which is used for the inspection for related substances of amino acid drugs to control the drug quality and guarantee the drug safety. Methods: The molecular structure of N, S-diacetylcysteine was confirmed by the methods of HPLC, IR, NMR and high resolution MS. Moreover, the moisture, residual solvents, residual ignition, inorganic ions and related substances of N, S-diacetylcysteine were all determined. HPLC, Mass Balance and NMR were applied to determine and calculate its content, and Mass Balance mehod was used for evaluating its final content. Finally, its hygroscopicity, homogeneity and short-term stability were also observed. Results and Conclusion: The results of experiments showed the structure of N, S-diacetylcysteine was confirmed, and its contents of moisture, inorganic ions and related substances were 0.05%, 0.21% and 0.90%, respectively. The residual solvents were not detected in the samples. The final content of N, S-diacetylcysteine reference standard was 98.8% by mass balance method. The content distribution of this batch of N, S-diacetylcysteine reference standard was uniform, and its short-term stability result proved that N, S-diacetylcysteine was stable.
[1] 樊迪, 李晓光,王紫,等. 蛋白质去乙酰化在相关疾病中的研究进展及治疗现状[J]. 中国现代医生,2024,62(12):124,127-131.
[2] 李大嘉,许丽艳,程银伟,等. 磷酸化或乙酰化修饰使Fascin的促癌功能翻转[J]. 中国生物化学与分子生物学报,2024,40(5):674-684.
[3] 蒋佳文,李善高. 组蛋白去乙酰化酶与炎症性疾病 [J].浙江医学,2024,46(7):776,780-784.
[4] 曾梦婷,黎明. 基于F-C反应合成多种二乙酰基单体[J].山西化工,2024,44(1):44-46.
[5] 金鑫,郑喆,秦娜,等. N-乙酰-L-半胱氨酸合成工艺优化[J]. 合成化学,2023,31(3):238-243.
[6] 陈征辉,晁强,高晓冬,等. 多萜醇N, N'-二乙酰壳二糖的合成[J]. 化学世界,2021,62(8):473-478.
[7] 张成耀. 由L-胱氨酸直接制备N-乙酰-L-半胱氨酸的工程研究[D]. 长春:吉林大学,2021.
[8] 丛林川. N-乙酰-L-半胱氨酸的绿色制备工艺开发研究[D]. 长春:吉林大学,2020.
[9] 左婷婷. N, N'-二乙酰-L-胱氨酸合成工艺的研究[D]. 长春:吉林大学,2019.
[10] 关瑾,董西鑫,丁爽,等. 毛细管电泳法分离分析乙酰半胱氨酸及四种相关杂质[J]. 分析试验室,2014, 33(4):412-415.
[11] 张玉婵,黄奇建,龙旺金. 采用HPLC法测定乙酰半胱氨酸颗粒中的主要降解产物[J]. 今日药学,2014,24(2):121,122-125.
[12] 仵淑红,郭栋,王丽霞. HPLC法测定乙酰半胱氨酸颗粒的含量[J]. 中国药师,2011,14(11):1627-1629.
[13] 王正俊,周春燕. 乙酰半胱氨酸泡腾颗粒中有关物质的测定[J]. 中国药业,2008(17):12-13.
[14] 王芳侠,徐创莉,陈赞民. HPLC法测定乙酰半胱氨酸颗粒中有关物质[J]. 中国热带医学,2007(9):1665,1667-1675.
[15] 何文秀,陆恩浩,陈依婷,等. 吸入用乙酰半胱氨酸溶液中有关物质的检测和质量评价[J]. 中国药物经济学,2019,14(8):37-41.
[16] 郭栋,仵淑红,王丽霞. 30 批次乙酰半胱氨酸颗粒质量评价[J]. 首都医药,2011,18(2):52-53.
[17] 代东梅,罗顺德,程天贵. 乙酰半胱氨酸胶囊的制备及质量控制[J]. 中国医院药学杂志,2004(5):8-10.